Currently, there are 765.21M common shares owned by the public and among those 753.73M shares have been available to trade.
The company’s stock has a 5-day price change of -5.79% and -50.40% over the past three months. XPEV shares are trading -40.85% year to date (YTD), with the 12-month market performance down to -6.30% lower. It has a 12-month low price of $7.51 and touched a high of $23.62 over the same period. XPEV has an average intraday trading volume of 11.66 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.28%, -23.59%, and -38.38% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of XPeng Inc ADR (NYSE: XPEV) shares accounts for 13.04% of the company’s 765.21M shares outstanding.
It has a market capitalization of $6.60B and a beta (3y monthly) value of 2.96. The earnings-per-share (ttm) stands at -$1.87. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.12% over the week and 3.97% over the month.
Analysts forecast that XPeng Inc ADR (XPEV) will achieve an EPS of -$0.45 for the current quarter, -$0.38 for the next quarter and -$1.07 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.52 while analysts give the company a high EPS estimate of -$0.35. Comparatively, EPS for the current quarter was -$0.39 a year ago. Earnings per share for the fiscal year are expected to increase by 9.41%, and 32.82% over the next financial year. EPS should grow at an annualized rate of -5.74% over the next five years, compared to -41.23% over the past 5-year period.
Looking at the support for the XPEV, a number of firms have released research notes about the stock. BofA Securities stated their Buy rating for the stock in a research note on August 21, 2023, with the firm’s price target at $22. CLSA coverage for the XPeng Inc ADR (XPEV) stock in a research note released on August 08, 2023 offered a Buy rating with a price target of $24. HSBC Securities was of a view on August 07, 2023 that the stock is Buy, while UBS gave the stock Neutral rating on July 31, 2023, issuing a price target of $23. Macquarie on their part issued Outperform rating on July 27, 2023.
